The coagulopathy of chronic liver disease: Is there a causal relationship with bleeding? Yes

European Journal of Internal Medicine

Volumn 21, Issue 2, 2010, Pages 62-64

  Basili, Stefania ^a   Raparelli, Valeria ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bleeding; Cirrhosis; Endotoxemia; Hyperfibrinolysis; Variceal hemorrhage

Indexed keywords

ARTICLE; BLEEDING; BLEEDING TIME; BLOOD CLOTTING DISORDER; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; ENDOTOXEMIA; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER FAILURE; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; RISK ASSESSMENT; RISK REDUCTION; SYSTEMIC CIRCULATION;

EID: 77549085528     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.01.005     Document Type: Note

References (31)

1. Graham D.Y., and Smith J.L. The course of patients after variceal hemorrhage. Gastroenterology 80 (1981) 800-809
2. El-Serag H.B., and Everhart J.E. Improved survival after variceal bleeding over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 95 (2000) 3566-3573
3. McCormick P.A., and O'Keefe C.O. Improving prognosis following a first variceal haemorrhage over four decades. Gut 49 (2001) 682-685
4. Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E.J., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-659
5. Reverter J.C. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemost 4 (2006) 717-720
6. Boberg K.M., Brosstad F., Egeland T., Egge T., and Schrumpf E. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?. Thromb Haemost 81 (1999) 378-381
7. De Franchis R., Arcidiacono P.G., Carpinelli L., Andreoni B., Cestari L., Brunati S., et al. Randomized controlled trial of desmopressin plus terlipressin versus terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club. Hepatology 18 (1993) 1102-1107
8. Basili S., Ferro D., Leo R., Juliano L., Alessandri C., Cordova C., et al. Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. J Hepatol 24 (1996) 574-580
9. Bosch J., Thabut D., Bendtsen F., D'Amico G., Albillos A., González Abraldes J., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
10. Bosch J., Thabut D., Albillos A., Carbonell N., Spicak J., Massard J., et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology 47 (2008) 1604-1614
11. Caldwell S.H., Hoffman M., Lisman T., Macik B.G., Northup P.G., Reddy K.R., et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 44 (2006) 1039-1046
12. Senzolo M., Burra P., Cholongitas E., and Burroughs A.K. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 12 (2006) 7725-7736
13. Joist J.H. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state. Am J Gastroenterol 9 (1999) 2801-2803
14. Francis Jr. R.B., and Feinstein D.I. Clinical significance of accelerated fibrinolysis in liver disease. Haemostasis 14 (1984) 460-465
15. Bertaglia E., Belmonte P., Vertolli U., Azzurro M., and Martines D. Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure?. Haemostasis 13 (1983) 328-334
16. Violi F., Ferro D., Basili S., Quintarelli C., Saliola M., Alessandri C., et al. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis. Hepatology 15 (1992) 672-676
17. Violi F., Basili S., Ferro D., Quintarelli C., Alessandril C., and Cordova C. Association between high values of d-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group. Thromb Haemost 76 (1996) 177-183
18. Marder V.J., and Sherry S. Thrombolytic therapy: current status. N Engl J Med 16 318 (1988) 1585-1595
19. Stricker R.B., Wong D., Shiu D.T., Reyes P.T., and Shuman M.A. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. Blood 68 (1986) 275-280
20. Adelman B., Michelson A.D., Greenberg J., and Handin R.I. Proteolysis of platelet glycoprotein Ib by plasmin is facilitated by plasmin lysine-binding regions. Blood 68 (1986) 1280-1284
21. Bosch J., and Reverter J.C. The coagulopathy of cirrhosis: myth or reality?. Hepatology 41 (2005) 434-435
22. Bernard B., Cadranel J.F., Valla D., Escolano S., Jarlier V., and Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 108 (1995) 1828-1834
23. Violi F., Ferro D., Basili S., Saliola M., Quintarelli C., Alessandri C., and Cordova C. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 109 (1995) 531-539
24. Saliola M., Lorenzet R., Ferro D., Basili S., Caroselli C., Santo A.D., et al. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Gut 43 (1998) 428-432
25. Goulis J., Patch D., and Burroughs A.K. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 353 (1999) 139-142
26. Bernard B., Grangé J.D., Khac E.N., Amiot X., Opolon P., and Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29 (1999) 1655-1661
27. Violi F., Ferro D., Basili S., D'Angelo A., Mazzola G., Quintarelli C., et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ 309 (1994) 239-240
28. Fimognari F.L., De Santis A., Piccheri C., Moscatelli R., Gigliotti F., Vestri A., et al. Evaluation of d-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med 146 (2005) 238-243
29. Prieto J., Yuste J.R., Beloqui O., Civeira M.P., Riezu J.I., Aguirre B., et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 23 (1996) 199-204
30. Amitrano L., Guardascione M.A., Brancaccio V., Margaglione M., Manguso F., Iannaccone L., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40 (2004) 736-741
31. Violi F., Ferro D., Basili S., Lionetti R., Rossi E., Merli M., et al. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost 77 (1997) 44-47